Terms: = Head and neck cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Clinical Outcome
14 results:
1. Immunoexpression of REGγ and apoptosis-related proteins in oral tongue squamous cell carcinoma.
Brasileiro Junior VL; Nonaka CFW; Gonzaga AKG; de Oliveira Ramos CC; Pereira Pinto L; Souza LB
Int J Oral Maxillofac Surg; 2022 Sep; 51(9):1138-1144. PubMed ID: 34955353
[TBL] [Abstract] [Full Text] [Related]
2. mdm2 and CDK4 amplifications are rare events in salivary duct carcinomas.
Grünewald I; Trautmann M; Busch A; Bauer L; Huss S; Schweinshaupt P; Vollbrecht C; Odenthal M; Quaas A; Büttner R; Meyer MF; Beutner D; Hüttenbrink KB; Wardelmann E; Stenner M; Hartmann W
Oncotarget; 2016 Nov; 7(46):75261-75272. PubMed ID: 27662657
[TBL] [Abstract] [Full Text] [Related]
3. Correlation of TP53 and mdm2 genotypes and clinical outcome in platinum-treated head and neck cancer patients with more than 10 years' follow-up.
Vivenza D; Monteverde M; Lattanzio L; Tonissi F; Astesana V; Denaro N; Comino A; Russi E; Lo Nigro C; Merlano M
Int J Biol Markers; 2016 May; 31(2):e183-92. PubMed ID: 26916894
[TBL] [Abstract] [Full Text] [Related]
4. Association of the recurrence of vocal leukoplakia with mdm2-309 variants over a 2-year period: a prospective study.
Zhou J; Yang Y; Zhang D; Zhou L; Liu F; Tao L; Lu LM
Acta Otolaryngol; 2016; 136(1):95-9. PubMed ID: 26371559
[TBL] [Abstract] [Full Text] [Related]
5. A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.
Sun LL; Wu JY; Wu ZY; Shen JH; Xu XE; Chen B; Wang SH; Li EM; Xu LY
Int J Cancer; 2015 Mar; 136(6):E569-77. PubMed ID: 25220908
[TBL] [Abstract] [Full Text] [Related]
6. Image cytometric analysis of p53 and mdm-2 expression in primary and recurrent mucoepidermoid carcinoma of parotid gland: immunohistochemical study.
Abd-Elhamid ES; Elmalahy MH
Diagn Pathol; 2010 Nov; 5():72. PubMed ID: 21092204
[TBL] [Abstract] [Full Text] [Related]
7. Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus.
Boonstra JJ; van Marion R; Tilanus HW; Dinjens WN
J Gastrointest Surg; 2011 Jan; 15(1):48-56. PubMed ID: 20922573
[TBL] [Abstract] [Full Text] [Related]
8. Correlation of p53, mdm2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma.
Cheng TH; Hsu PK; Li AF; Hung IC; Huang MH; Hsu HS
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1577-82. PubMed ID: 19488782
[TBL] [Abstract] [Full Text] [Related]
9. P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis.
Hafkamp HC; Mooren JJ; Claessen SM; Klingenberg B; Voogd AC; Bot FJ; Klussmann JP; Hopman AH; Manni JJ; Kremer B; Ramaekers FC; Speel EJ
Mod Pathol; 2009 May; 22(5):686-98. PubMed ID: 19305381
[TBL] [Abstract] [Full Text] [Related]
10. The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression.
Ferru A; Fromont G; Gibelin H; Guilhot J; Savagner F; Tourani JM; Kraimps JL; Larsen CJ; Karayan-Tapon L
Br J Cancer; 2006 Dec; 95(12):1670-7. PubMed ID: 17117177
[TBL] [Abstract] [Full Text] [Related]
11. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.
Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Nov; 94(5):593-600. PubMed ID: 12424454
[TBL] [Abstract] [Full Text] [Related]
12. [Prognostic factors of esophageal cancer].
Kitagawa Y; Ueda M; Ando N; Ozawa S; Takeuchi H; Kitajima M
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2011-20. PubMed ID: 9838901
[TBL] [Abstract] [Full Text] [Related]
13. Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy.
Shimada Y; Imamura M; Shibagaki I; Tanaka H; Miyahara T; Kato M; Ishizaki K
Ann Surg; 1997 Aug; 226(2):162-8. PubMed ID: 9296509
[TBL] [Abstract] [Full Text] [Related]
14. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.
Ahomadegbe JC; Barrois M; Fogel S; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
Oncogene; 1995 Mar; 10(6):1217-27. PubMed ID: 7700647
[TBL] [Abstract] [Full Text] [Related]
